Section 58-29F-6 - Recoupment or chargeback criteriaFor recoupment or chargeback, the following criteria apply:
(1) Audit parameters shall consider consumer-oriented parameters based on manufacturer listings;(2) A pharmacy's usual and customary price for compounded medications is considered the reimbursable cost unless the pricing methodology is outlined in the provider contract;(3) A finding of overpayment or underpayment can only be based on the actual overpayment or underpayment and not a projection based on the number of patients served having a similar diagnosis or on the number of similar orders or refills for similar drugs;(4) The entity conducting the audit may not use extrapolation in calculating the recoupment or penalties for audits unless required by state or federal law or regulation;(5) Calculations of overpayments may not include dispensing fees unless:(a) A prescription was not actually dispensed;(b) The prescriber denied authorization;(c) The prescription dispensed was a medication error by the pharmacy; or(d) The identified overpayment is solely based on an extra dispensing fee;(6) An entity may not consider any clerical or record-keeping error, such as a typographical error, scrivener's error, or computer error regarding a required document or record as fraud. However, such errors may be subject to recoupment;(7) In the case of errors that have no actual financial harm to the patient or plan, the pharmacy benefits manager may not assess any chargebacks. Errors that are a result of the pharmacy's failing to comply with a formal corrective action plan may be subject to recovery; and(8) Interest may not accrue during the audit period for either party. The audit period begins with the notice of the audit and ends with the final audit report.